Evidence map›Paper›PMID 22484810›Full record

ArticleMycopathologia2012

RNA-mediated gene silencing in Candida albicans: inhibition of hyphae formation by use of RNAi technology.

Maryam Moazeni, Mohammad Reza Khoramizadeh, Parivash Kordbacheh, Zargham Sepehrizadeh, Hojat Zeraati, Fatemeh Noorbakhsh, Ladan Teimoori-Toolabi, Sassan Rezaie

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Overcoming antifungal resistance inFrontiers in cellular and infection microbiology · 2025
    Review
  2. Article
  3. RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens.Methods in molecular biology (Clifton, N.J.) · 2024
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Maryam MoazeniDivision of Molecular Biology, Department of Medical Mycology and Parasitology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Reza Khoramizadeh
Parivash Kordbacheh
Zargham Sepehrizadeh
Hojat Zeraati
Fatemeh Noorbakhsh
Ladan Teimoori-Toolabi
Sassan Rezaie
Tehran University of Medical Sciences · IRBiotechnology Research Center · IRIslamic Azad University of Varamin · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The introduction of RNA silencing machinery in fungi has led to the promising application of RNAi methodology to knock down essential vital factor or virulence factor genes in the microorganisms. Efg1p is required for development of a true hyphal growth form which is known to be essential for interactions with human host cells and for the yeast's pathogenesis. In this paper, we describe the development of a system for presenting and studying the RNAi function on the EFG1 gene in C. albicans. The 19-nucleotide siRNA was designed on the basis of the cDNA sequence of the EFG1 gene in C. albicans and transfection was performed by use of a modified-PEG/LiAc method. To investigate EFG1 gene silencing in siRNA-treated cells, the yeasts were grown in human serum; to induce germ tubes a solid medium was used with the serum. Quantitative changes in expression of the EFG1 gene were analyzed by measuring the cognate EFG1 mRNA level by use of a quantitative real-time RT-PCR assay. Compared with the positive control, true hyphae formation was significantly reduced by siRNA at concentrations of 1 μM, 500 nM, and 100 nM (P < 0.05). In addition, siRNA at a concentration of 1 μM was revealed to inhibit expression of the EFG1 gene effectively (P < 0.05). On the basis of the potential of post-transcriptional gene silencing to control the expression of specific genes, these techniques may be regarded as promising means of drug discovery, with applications in biomedicine and functional genomics analysis.

Indexed as

RNA InterferenceAntifungal AgentsBiological ProductsCandida albicansDNA-Binding ProteinsFungal ProteinsGene Expression ProfilingHumansHyphaeReal-Time Polymerase Chain ReactionRNA, FungalRNA, Small InterferingTranscription FactorsAntifungal AgentsBiological ProductsDNA-Binding ProteinsEFG1 protein, Candida albicansFungal ProteinsRNA, FungalRNA, Small InterferingTranscription Factors

Identifiers

PMID22484810
OpenAlexW1982805343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.